15.213 articles found

Pilot randomised controlled trial of a novel form of exercise on parkinsonism symptoms.

Sinclair B, Bertram KL, Clough M, Gamage SM, Vivash L, Tang HM, Boonstra F, Moses J, Lindsay E, Major B, Fan S, Varley S, Turner L, White O, Kolbe S, Fielding J, Lannin NA, Law M, O'Brien TJ.

BMJ Neurol Open · 2026-01-05

DOI: 10.1136/bmjno-2025-001248PMID: 41509521

Efficacy and safety of repetitive transcranial magnetic stimulation on motor function, depression, and cognitive dysfunction in Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials.

Lu W, Yan L, Li C, Wang K, Wang Q, Xu S, Wang B.

Clin Park Relat Disord · 2026-01-05

DOI: 10.1016/j.prdoa.2026.100422PMID: 41624991

Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkinson's disease: Longitudinal effects of CPAP therapy.

Zhu S, An D, Liu X.

Sleep Med · 2026-01-05

DOI: 10.1016/j.sleep.2026.108766PMID: 41499940

Five-Year Follow-Up of Photobiomodulation in Parkinson's Disease: A Case Series Exploring Clinical Stability and Microbiome Modulation.

Bicknell B, Liebert A, McLachlan C, Kiat H.

J Clin Med · 2026-01-04

DOI: 10.3390/jcm15010368PMID: 41517622

Comparison of clinical features and cerebral glucose metabolism between patients with major depressive disorder and Parkinson's with depression.

Liu M, Xie X, Liu Y, Feng H, Wang X, Du X, Zhang H.

BMC Psychiatry · 2026-01-03

DOI: 10.1186/s12888-025-07750-yPMID: 41485002

Feasibility and potential effects of mental imagery training on subjective cognitive function and brain connectivity in people with Parkinson's disease: A randomized pilot trial.

Cherry J, Nelson AM, Robinson LA, Goldstein J, Vives-Rodriguez A, Sharp E, Tinaz S.

Neuropsychol Rehabil · 2026-01-03

DOI: 10.1080/09602011.2025.2608220PMID: 41482867

Preclinical biodistribution and safety evaluation of human iPSC-derived dopaminergic neural progenitor cells for Parkinson's disease.

Huang Y, Wen H, Li L, Li L, Li Q, Qin C, Mao Y, Lin Z, Jiang H, Zhu F, Li X, Geng X.

Front Cell Dev Biol · 2026-01-02

DOI: 10.3389/fcell.2025.1701748PMID: 41552012

Synergistic integration of clinical and multi-omics data for early MCI diagnosis using an attention-based graph fusion network.

Yu S, Zhao J, Ouyang J, Wang X, Kou P, Zhu K, Liu P.

J Neurosci Methods · 2026-01-02

DOI: 10.1016/j.jneumeth.2025.110664PMID: 41485703

Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson’s Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Ahmed A, Ahmed O, Dishean A, Gilbert C, Elkheir M, Sota H, Abdulaziz M, Mahmoud E, Ahmed R.

Parkinson's disease · 2026-01-01

Visual feedback increases expiratory muscle training effort in Parkinson’s disease: a randomised crossover trial

Srp M, Dvorakova K, Muzik J, Janderova P, Sevcik M, Matys V, Vitek J, Kliment R, Hoskovcova M, Ruzicka E.

Journal of neuroengineering and rehabilitation · 2026-01-01

Odor‐Specific Symptoms in Parkinson’s Disease—UPSIT‐TC Odor Identification Status Versus Clinical Severity

Lin T, Yang L, Lin Y, Lei H, Chiu S, Fang T, Chang M, Guo Y.

Parkinson's disease · 2026-01-01

Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety Study.

Stocchi F, Bravi D, Radicati FG, Coletti C, Vacca L.

Curr Neuropharmacol · 2026-01-01

DOI: 10.2174/011570159x361647250416072053PMID: 40457975